QRD Human Product Information Template
5 4.6 Fertility, pregnancy and lactation [For pregnancy and lactation statements, see Appendix I.] [Additional sub-headings such as “Women of childbearing potential”, “Contraception in males and
Download QRD Human Product Information Template
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
9th STEP WORKSHEET Made direct amends to such people ...
www.batonrougealanon.org9th STEP WORKSHEET Made direct amends to such people wherever possible, except when to do so would injure them or others. 1. Person (Alcoholics Anonymous, Alcoholics …
BAUSCH+LOMB Horizon Rewards Visa Incentive Card ®or …
www.centralaccesscard.comDOCS-#5864233-v2 BAUSCH+LOMB Horizon Rewards Visa® Incentive Card ®or BAUSCH+LOMB Horizon Rewards Visa Virtual Account - Accountholder Agreement. This document constitutes the agreement ("Agreement") outlining the terms and conditions under which this BAUSCH+LOMB Horizon Rewards Visa Incentive Card (“Card”)
The Veterans’ Transition Review
www.veteranstransition.co.uk7 In the year to last November, 22,5301 personnel left the Regular Armed Forces: 14,520 from the Army, 4,010 from the Royal Navy and 4,000 from the RAF. The transition from Service to civilian life
Valuing Stock Appreciation Rights (SARs) in ESOP Sponsor ...
www.willamette.com56 INSIGHTS • WINTER 2011 www .willamette .com Valuing Stock Appreciation Rights (SARs) in ESOP Sponsor Companies. Steve Whittington. ESOP Valuation Insights. Stock appreciation rights (SARs) are used in conjunction with ESOP stock purchase